Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis

The paper presents the data available in the literature on the efficacy and tolerability of basic tumor necrosis factor α inhibitors (TNF α) etanercept, adalimumab, infliximab in the treatment of psoriatic arthritis (PsA) and their effects on the major manifestations of this disease - cutaneous and...

Full description

Bibliographic Details
Main Authors:	Vladimir Vasilyevich Badokin, I A Troshkina, Yu L Korsakova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2010-12-01
Series:	Современная ревматология
Subjects:	tumor necrosis factor-α inhibitors psoriatic arthritis
Online Access:	https://mrj.ima-press.net/mrj/article/view/326

id	doaj-f79b45641ce4429a8a0729a6bf7f7fda
record_format	Article
spelling	doaj-f79b45641ce4429a8a0729a6bf7f7fda2021-07-29T09:00:06ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2010-12-0144727610.14412/1996-7012-2010-6411631Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritisVladimir Vasilyevich BadokinI A TroshkinaYu L KorsakovaThe paper presents the data available in the literature on the efficacy and tolerability of basic tumor necrosis factor α inhibitors (TNF α) etanercept, adalimumab, infliximab in the treatment of psoriatic arthritis (PsA) and their effects on the major manifestations of this disease - cutaneous and articular syndromes. It generalizes the authors experience in treating PA with infliximab. The value of TNF α inhibitors in the complex therapy of PsA and indications for their use in this disease are analyzedhttps://mrj.ima-press.net/mrj/article/view/326tumor necrosis factor-α inhibitorspsoriatic arthritis
collection	DOAJ
language	Russian
format	Article
sources	DOAJ
author	Vladimir Vasilyevich Badokin I A Troshkina Yu L Korsakova
spellingShingle	Vladimir Vasilyevich Badokin I A Troshkina Yu L Korsakova Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis Современная ревматология tumor necrosis factor-α inhibitors psoriatic arthritis
author_facet	Vladimir Vasilyevich Badokin I A Troshkina Yu L Korsakova
author_sort	Vladimir Vasilyevich Badokin
title	Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
title_short	Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
title_full	Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
title_fullStr	Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
title_full_unstemmed	Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
title_sort	tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
publisher	IMA-PRESS LLC
series	Современная ревматология
issn	1996-7012 2310-158X
publishDate	2010-12-01
description	The paper presents the data available in the literature on the efficacy and tolerability of basic tumor necrosis factor α inhibitors (TNF α) etanercept, adalimumab, infliximab in the treatment of psoriatic arthritis (PsA) and their effects on the major manifestations of this disease - cutaneous and articular syndromes. It generalizes the authors experience in treating PA with infliximab. The value of TNF α inhibitors in the complex therapy of PsA and indications for their use in this disease are analyzed
topic	tumor necrosis factor-α inhibitors psoriatic arthritis
url	https://mrj.ima-press.net/mrj/article/view/326
work_keys_str_mv	AT vladimirvasilyevichbadokin tumornecrosisfactorinhibitorsintherapyforpsoriaticarthritis AT iatroshkina tumornecrosisfactorinhibitorsintherapyforpsoriaticarthritis AT yulkorsakova tumornecrosisfactorinhibitorsintherapyforpsoriaticarthritis
_version_	1721250450217369600

Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis

Similar Items